Literature DB >> 30778725

Gene panel sequencing identifies a likely monogenic cause in 7% of 235 Pakistani families with nephrolithiasis.

Ali Amar1,2, Amar J Majmundar1, Ihsan Ullah1, Ayesha Afzal2, Daniela A Braun1, Shirlee Shril1, Ankana Daga1, Tilman Jobst-Schwan1, Mumtaz Ahmad3, John A Sayer4,5,6, Heon Yung Gee7, Jan Halbritter8, Thomas Knöpfel9,10, Nati Hernando9, Andreas Werner11, Carsten Wagner9,10, Shagufta Khaliq2, Friedhelm Hildebrandt12.   

Abstract

Nephrolithiasis (NL) affects 1 in 11 individuals worldwide and causes significant patient morbidity. We previously demonstrated a genetic cause of NL can be identified in 11-29% of pre-dominantly American and European stone formers. Pakistan, which resides within the Afro-Asian stone belt, has a high prevalence of nephrolithiasis (12%) as well as high rate of consanguinity (> 50%). We recruited 235 Pakistani subjects hospitalized for nephrolithiasis from five tertiary hospitals in the Punjab province of Pakistan. Subjects were surveyed for age of onset, NL recurrence, and family history. We conducted high-throughput exon sequencing of 30 NL disease genes and variant analysis to identify monogenic causative mutations in each subject. We detected likely causative mutations in 4 of 30 disease genes, yielding a likely molecular diagnosis in 7% (17 of 235) of NL families. Only 1 of 17 causative mutations was identified in an autosomal recessive disease gene. 10 of the 12 detected mutations were novel mutations (83%). SLC34A1 was most frequently mutated (12 of 17 solved families). We observed a higher frequency of causative mutations in subjects with a positive NL family history (13/109, 12%) versus those with a negative family history (4/120, 3%). Five missense SLC34A1 variants identified through genetic analysis demonstrated defective phosphate transport. We examined the monogenic causes of NL in a novel geographic cohort and most frequently identified dominant mutations in the sodium-phosphate transporter SLC34A1 with functional validation.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30778725      PMCID: PMC6426152          DOI: 10.1007/s00439-019-01978-x

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  23 in total

Review 1.  The management of stone disease.

Authors:  S A H Rizvi; S A A Naqvi; Z Hussain; A Hashmi; M Hussain; M N Zafar; H Mehdi; R Khalid
Journal:  BJU Int       Date:  2002-03       Impact factor: 5.588

2.  Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities.

Authors:  L Beck; A C Karaplis; N Amizuka; A S Hewson; H Ozawa; H S Tenenhouse
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

3.  Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis.

Authors:  Jan Halbritter; Michelle Baum; Ann Marie Hynes; Sarah J Rice; David T Thwaites; Zoran S Gucev; Brittany Fisher; Leslie Spaneas; Jonathan D Porath; Daniela A Braun; Ari J Wassner; Caleb P Nelson; Velibor Tasic; John A Sayer; Friedhelm Hildebrandt
Journal:  J Am Soc Nephrol       Date:  2014-10-08       Impact factor: 10.121

4.  Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter.

Authors:  Dominique Prié; Virginie Huart; Naziha Bakouh; Gabrielle Planelles; Olivier Dellis; Bénédicte Gérard; Philippe Hulin; François Benqué-Blanchet; Caroline Silve; Bernard Grandchamp; Gérard Friedlander
Journal:  N Engl J Med       Date:  2002-09-26       Impact factor: 91.245

5.  Exome sequencing identifies a novel homozygous mutation in the phosphate transporter SLC34A1 in hypophosphatemia and nephrocalcinosis.

Authors:  Abbhirami Rajagopal; Débora Braslavsky; James T Lu; Soledad Kleppe; Florencia Clément; Hamilton Cassinelli; David S Liu; Jose Miguel Liern; Graciela Vallejo; Ignacio Bergadá; Richard A Gibbs; Phillipe M Campeau; Brendan H Lee
Journal:  J Clin Endocrinol Metab       Date:  2014-07-22       Impact factor: 5.958

6.  Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A.

Authors:  I Richard; O Broux; V Allamand; F Fougerousse; N Chiannilkulchai; N Bourg; L Brenguier; C Devaud; P Pasturaud; C Roudaut
Journal:  Cell       Date:  1995-04-07       Impact factor: 41.582

7.  High-throughput mutation analysis in patients with a nephronophthisis-associated ciliopathy applying multiplexed barcoded array-based PCR amplification and next-generation sequencing.

Authors:  Jan Halbritter; Katrina Diaz; Moumita Chaki; Jonathan D Porath; Brendan Tarrier; Clementine Fu; Jamie L Innis; Susan J Allen; Robert H Lyons; Constantinos J Stefanidis; Heymut Omran; Neveen A Soliman; Edgar A Otto
Journal:  J Med Genet       Date:  2012-12       Impact factor: 6.318

8.  A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome.

Authors:  Carolin E Sadowski; Svjetlana Lovric; Shazia Ashraf; Werner L Pabst; Heon Yung Gee; Stefan Kohl; Susanne Engelmann; Virginia Vega-Warner; Humphrey Fang; Jan Halbritter; Michael J Somers; Weizhen Tan; Shirlee Shril; Inès Fessi; Richard P Lifton; Detlef Bockenhauer; Sherif El-Desoky; Jameela A Kari; Martin Zenker; Markus J Kemper; Dominik Mueller; Hanan M Fathy; Neveen A Soliman; Friedhelm Hildebrandt
Journal:  J Am Soc Nephrol       Date:  2014-10-27       Impact factor: 10.121

9.  Whole exome sequencing identifies causative mutations in the majority of consanguineous or familial cases with childhood-onset increased renal echogenicity.

Authors:  Daniela A Braun; Markus Schueler; Jan Halbritter; Heon Yung Gee; Jonathan D Porath; Jennifer A Lawson; Rannar Airik; Shirlee Shril; Susan J Allen; Deborah Stein; Adila Al Kindy; Bodo B Beck; Nurcan Cengiz; Khemchand N Moorani; Fatih Ozaltin; Seema Hashmi; John A Sayer; Detlef Bockenhauer; Neveen A Soliman; Edgar A Otto; Richard P Lifton; Friedhelm Hildebrandt
Journal:  Kidney Int       Date:  2016-02       Impact factor: 10.612

10.  Clinical, biochemical, and pathophysiological analysis of SLC34A1 mutations.

Authors:  Amy Fearn; Benjamin Allison; Sarah J Rice; Noel Edwards; Jan Halbritter; Soline Bourgeois; Eva M Pastor-Arroyo; Friedhelm Hildebrandt; Velibor Tasic; Carsten A Wagner; Nati Hernando; John A Sayer; Andreas Werner
Journal:  Physiol Rep       Date:  2018-06
View more
  13 in total

1.  Digenic Heterozygous Mutations in SLC34A3 and SLC34A1 Cause Dominant Hypophosphatemic Rickets with Hypercalciuria.

Authors:  Rebecca J Gordon; Dong Li; Daniel Doyle; Joshua Zaritsky; Michael A Levine
Journal:  J Clin Endocrinol Metab       Date:  2020-07-01       Impact factor: 5.958

2.  A comparison of the clinical characteristics of pediatric urolithiasis patients with positive and negative molecular diagnoses.

Authors:  Yining Zhao; Xiaoliang Fang; Lei He; Yanjie Fan; Yueyan Li; Guofeng Xu; Yongguo Yu; Hongquan Geng
Journal:  World J Urol       Date:  2022-02-12       Impact factor: 4.226

Review 3.  The genetics of kidney stone disease and nephrocalcinosis.

Authors:  Prince Singh; Peter C Harris; David J Sas; John C Lieske
Journal:  Nat Rev Nephrol       Date:  2021-12-14       Impact factor: 28.314

4.  Perception of Dietary Influences on Renal Stone Formation Among the General Population.

Authors:  Ahmad Bashir; Sahar K Zuberi; Bazil Musharraf; Hasan Khan; M Hammad Ather
Journal:  Cureus       Date:  2022-06-16

5.  Genetic Alterations, DNA Methylation, Alloantibodies and Phenotypic Heterogeneity in Type III von Willebrand Disease.

Authors:  Muhammad Asif Naveed; Aiysha Abid; Nadir Ali; Yaqoob Hassan; Ali Amar; Aymen Javed; Khansa Qamar; Ghulam Mustafa; Ali Raza; Umera Saleem; Shabbir Hussain; Madiha Shakoor; Shagufta Khaliq; Shahida Mohsin
Journal:  Genes (Basel)       Date:  2022-05-28       Impact factor: 4.141

6.  Genetic Polymorphisms and Kidney Stones Around the Globe: A Systematic Review and Meta-Analysis.

Authors:  Abdolreza Mohammadi; Alireza Namazi Shabestari; Leila Zareian Baghdadabad; Fatemeh Khatami; Leonardo Oliveira Reis; Mahin Ahmadi Pishkuhi; Seyed Mohammad Kazem Aghamir
Journal:  Front Genet       Date:  2022-06-30       Impact factor: 4.772

7.  Genetic testing enables a precision medicine approach for nephrolithiasis and nephrocalcinosis in pediatrics: a single-center cohort.

Authors:  Lin Huang; Chang Qi; Gaohong Zhu; Juanjuan Ding; Li Yuan; Jie Sun; Xuelian He; Xiaowen Wang
Journal:  Mol Genet Genomics       Date:  2022-05-25       Impact factor: 2.980

8.  Whole-exome sequencing and variant spectrum in children with suspected inherited renal tubular disorder: the East India Tubulopathy Gene Study.

Authors:  Rajiv Sinha; Subal Pradhan; Sushmita Banerjee; Afsana Jahan; Shakil Akhtar; Amitava Pahari; Sumantra Raut; Prince Parakh; Surupa Basu; Priyanka Srivastava; Snehamayee Nayak; S G Thenral; V Ramprasad; Emma Ashton; Detlef Bockenhauer; Kausik Mandal
Journal:  Pediatr Nephrol       Date:  2022-01-10       Impact factor: 3.651

9.  Isolated nephrocalcinosis due to compound heterozygous mutations in renal outer medullary potassium channel.

Authors:  Priyanka Khandelwal; Jasintha Sabanadesan; Aditi Sinha; Pankaj Hari; Arvind Bagga
Journal:  CEN Case Rep       Date:  2020-03-17

Review 10.  Bartter's syndrome: clinical findings, genetic causes and therapeutic approach.

Authors:  Flavia Cristina Carvalho Mrad; Sílvia Bouissou Morais Soares; Luiz Alberto Wanderley de Menezes Silva; Pedro Versiani Dos Anjos Menezes; Ana Cristina Simões-E-Silva
Journal:  World J Pediatr       Date:  2020-06-01       Impact factor: 2.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.